70 likes | 83 Views
High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period.
E N D
Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com
Market Summary High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period. According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%.
Our Approach Market Summary According to the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or pre-diabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Through the use of portable blood analysers, testing at the “point of care” streamlines the diagnostic process and helps ensure patients receive the most effective and efficient care when and where it is needed. Point-of-care (POC) diagnostic testing permits staff to make speedy triage and treatment decisions when diagnosing a patient’s condition or monitoring a treatment response. By simplifying the testing process, clinicians can focus on what matters most—providing effective, quality patient care. Get a Free Sample PDF Report to understand our report before you purchase:https://www.reportsanddata.com/sample-enquiry-form/1507
Our Approach Market Summary Key participants include Abbott, F. Hoffmann-La Roche and Siemens Healthineers. Segments covered in the report: Product Type (Revenue, USD Million; 2016–2026) Glucose Monitoring Products Cardiometabolic Testing Products Infectious Disease Testing Products Coagulation Testing Products PT/INR Testing Products Activated Clotting Time (ACT/APTT) Testing Products Pregnancy and Fertility Testing Products Pregnancy Testing Products Other POC Products
Our Approach Market Summary Platform Type (Revenue, USD Million; 2016–2026) Agglutination assays Biosensors Dipsticks Lateral Flow Assays Microfluidics Molecular Diagnostics Solid phase Prescription Mode (Revenue, USD Million; 2016–2026) Prescription-based Testing OTC Testing
Our Approach Market Summary End User (Revenue, USD Million; 2016–2026) Professional Diagnostic Centres Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings) Hospitals/Critical Care Centres Home Care Research Laboratories Other End Users Do you have questions about the Report or want to inquire about a Discount? Ask our Expert: https://www.reportsanddata.com/discount-enquiry-form/1507
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Our Approach About Us